These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12685403)

  • 1. [Albarel (rilmenidin)--a selective I1 imidazole receptor agonist. Pharmacologic properties and experience in clinical use].
    Khirmanov VN
    Ter Arkh; 2003; 75(2):85-8. PubMed ID: 12685403
    [No Abstract]   [Full Text] [Related]  

  • 2. [Imidazole receptor agonists--a new advance in the treatment of hypertension?].
    Spinar J; Vítovec J
    Vnitr Lek; 2000 Feb; 46(2):122-5. PubMed ID: 11048538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Central nervous system as a target for the new antihypertensive agents].
    Nurminen ML
    Duodecim; 1999; 115(20):2267-73. PubMed ID: 11973931
    [No Abstract]   [Full Text] [Related]  

  • 4. Second International Symposium on Rilmenidine. Paris, March 11, 1988. Proceedings.
    Am J Med; 1989 Sep; 87(3C):1S-74S. PubMed ID: 2782322
    [No Abstract]   [Full Text] [Related]  

  • 5. [New trends in the treatment of arterial hypertension: identification of the I1 receptor and the pharmacology of imidazoline].
    Pavlović P
    Vojnosanit Pregl; 1998; 55(3):305-10. PubMed ID: 9720446
    [No Abstract]   [Full Text] [Related]  

  • 6. [Imidazoline receptors and use of drug blocking receptors I1].
    Lada W
    Pol Merkur Lekarski; 1996 Aug; 1(2):124-5. PubMed ID: 9156911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of I1 imidazoline receptors in the sympathoinhibition produced by intracisternally administered rilmenidine and moxonidine.
    Szabo B; Urban R
    Arzneimittelforschung; 1997 Sep; 47(9):1009-15. PubMed ID: 9342413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Imidazole receptors: site of action of a new generation of antihypertensive drugs. Current status and future prospects].
    Molderings GJ; Michel MC; Göthert M; Christen O; Schäfer SG
    Dtsch Med Wochenschr; 1992 Jan; 117(2):67-71. PubMed ID: 1346103
    [No Abstract]   [Full Text] [Related]  

  • 10. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [[Central agents in arterial hypertension: back to the future].
    Robles NR
    Nefrologia; 2000; 20(4):302-10. PubMed ID: 11039256
    [No Abstract]   [Full Text] [Related]  

  • 12. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Imidazole receptors and blood pressure regulation. High receptor selectivity of moxonidine].
    Molderings GJ; Göthert M; Christen O; Schäfer SG
    Dtsch Med Wochenschr; 1993 Jun; 118(25):953-8. PubMed ID: 8100191
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of clonidine (ST 155) and BAY a6781 on the isolated rabbit heart].
    Werner U; Starke K; Schümann HJ
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):474-5. PubMed ID: 4253890
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharma-clinics. Medication of the month. Moxonidine (Moxon)].
    Scheen AJ
    Rev Med Liege; 2000 Jan; 55(1):61-3. PubMed ID: 10803041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New, modern, centrally active antihypertensive agents in the treatment of essential hypertension].
    Sevcík J; Masek K
    Cas Lek Cesk; 1999 Jun; 138(12):359-62. PubMed ID: 10566202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers.
    Tyagarajan S; Chakravarty PK; Zhou B; Fisher MH; Wyvratt MJ; Lyons K; Klatt T; Li X; Kumar S; Williams B; Felix J; Priest BT; Brochu RM; Warren V; Smith M; Garcia M; Kaczorowski GJ; Martin WJ; Abbadie C; McGowan E; Jochnowitz N; Parsons WH
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5536-40. PubMed ID: 20709552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of I1-selective agents in the management of syndrome X.
    de Luca N; Argengiano L; Izzo R; Guerrera L; Iovino GL; Trimarco B
    Rev Port Cardiol; 2000 Apr; 19 Suppl 2():II33-5. PubMed ID: 10874855
    [No Abstract]   [Full Text] [Related]  

  • 19. [New central agents in the treatment of arterial hypertension].
    Robles NR
    An Med Interna; 1999 Oct; 16(10):495-7. PubMed ID: 10603665
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective imidazoline receptor agonists for metabolic syndrome.
    Krentz AJ; Evans AJ
    Lancet; 1998 Jan; 351(9097):152-3. PubMed ID: 9449863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.